Open Journal of Blood Diseases

Vol.4 No.1(2014), Paper ID 43869, 8 pages

DOI:10.4236/ojbd.2014.41001

 

Reinduction Chemotherapy with Gemtuzumab Ozogamicin and Intermediate/High-Dose Cytarabine: A Single-Center Experience

 

Sohsuke Meshitsuka, Mitsuo Hori, Shoichi Mitsuhashi, Yasushi Okoshi, Hiroshi Kojima

 

Department of Clinical Oncology, Ibaraki Prefectural Central Hospital, Ibaraki, Japan
Department of Hematology, Ibaraki Prefectural Central Hospital, Ibaraki, Japan
Department of Clinical Oncology, Ibaraki Prefectural Central Hospital, Ibaraki, Japan
Department of Hematology, Ibaraki Prefectural Central Hospital, Ibaraki, Japan; Ibaraki Clinical Education and Training Center, University of Tsukuba Hospital, Ibaraki, Japan
Department of Clinical Oncology, Ibaraki Prefectural Central Hospital, Ibaraki, Japan

 

Copyright © 2014 Sohsuke Meshitsuka, Mitsuo Hori, Shoichi Mitsuhashi, Yasushi Okoshi, Hiroshi Kojima et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article


Meshitsuka, S. , Hori, M. , Mitsuhashi, S. , Okoshi, Y. and Kojima, H. (2014) Reinduction Chemotherapy with Gemtuzumab Ozogamicin and Intermediate/High-Dose Cytarabine: A Single-Center Experience. Open Journal of Blood Diseases, 4, 1-8. doi: 10.4236/ojbd.2014.41001.

Copyright © 2022 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.